Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19245780 | 0.91 | CA12 (0.47) | TSHRKCNH2MEN1KMT2AHTR2A | |
| SCHEMBL17177095 | 0.90 | KCNH2 (0.49) | TSHRKCNH2MEN1KMT2AHTR2A | |
| SCHEMBL17164147 | 0.90 | KCNH2 (0.49) | TSHRKCNH2MEN1KMT2AHTR2A | |
| SCHEMBL19212464 | 0.86 | CA12 (0.47) | TSHRKCNH2MEN1KMT2AHTR2A | |
| SCHEMBL6621881 | 0.86 | CA12 (0.47) | TSHRKCNH2MEN1KMT2AHTR2A | |
| SCHEMBL19245593 | 0.86 | CA12 (0.47) | TSHRKCNH2MEN1KMT2AHTR2A | |
| SCHEMBL17164079 | 0.84 | CDC25C (0.43) | TSHRKCNH2MEN1KMT2AHTR2A | |
| SCHEMBL16609243 | 0.82 | CYP51A1 (0.42) | MEN1KMT2AALDH1A1 | |
| SCHEMBL6618592 | 0.80 | MEN1 (0.48) | TSHRKCNH2MEN1KMT2AHTR2A | |
| SCHEMBL6618598 | 0.80 | MEN1 (0.48) | TSHRKCNH2MEN1KMT2AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015044965-A1 | A PROCESS FOR PREPARATION OF MIRABEGRON AND ALPHA CRYSTALLINE FORM THEREOF | MEGAFINE PHARMA (P) LTD. (IN) | 2015-04-02 | — | — | WO | disclosed |